Indeed, using GnRH agonists to trigger ovulation before OPU has been shown to dramatically lower the risk of ovarian hyperstimulation syndrome [6,10,24] and shorten the luteal phase, possibly allowing a second COS if feasible [18,28,31,32]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.